Servier
Patient-Centric Drug Development R&D
- B2B
- B2G
- Has physical offices
- Manufacturing
- Sales-led purchase
About Servier
Develops pharmaceuticals focused on cardiology, venous diseases, oncology, neurology, and rare diseases, prioritizing patient needs and investing heavily in research.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- suresnes, Île-de-France, France
- Founded
- 1954
- Revenue
- €3BFY2025, filed accounts, INPI
- SIREN
- 085480796
- Website
- servier.com
- linkedin.com/company/servier
Jobs at Servier
Servier in the news
- Servier pays $70M upfront for Black Diamond’s RAS- and RAF-targeted cancer drug
Servier paid $70M upfront to acquire an early-stage RAS- and RAF-targeted cancer drug from Black Diamond Therapeutics.
- Oncology Research and Therapeutic Innovations at EANS 2026 – Servier
Servier is attending EANS 2026 to present its oncology research and targeted therapies for various cancers.
- Servier Partners with Veeva to Build Global Data Foundation
Servier collaborates with Veeva to standardize global customer data, enhance AI applications, and improve sales and medical team efficiency through integrated data solutions.
- Servier completes takeover of Day One Biopharmaceuticals stock
Servier finalized its acquisition of Day One Biopharmaceuticals for $2.5 billion, delisting the company from Nasdaq.
Servier at a glance
Servier is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in suresnes, Île-de-France, France.
Servier was founded in 1954.
Servier has 10,000+ employees.
Servier's revenue is €3B (FY2025, filed accounts, INPI).
Servier's SIREN number is 085480796.
Servier is hiring: 8 recent open roles, including Technicien RMN et IR F/H, BI & Data Lead, Opérateur.ice de production en alternance.
Selling to companies like Servier?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies